ClinicalTrials.Veeva

Menu

Effect of Liquid Volume and the Amount of Incorporated Gas Into a Carbohydrate/Protein Beverage on Satiety

Unilever logo

Unilever

Status

Completed

Conditions

Satiety
Appetite

Treatments

Dietary Supplement: Beverage 1
Dietary Supplement: Beverage 4
Dietary Supplement: Beverage 9
Dietary Supplement: Beverage 2
Dietary Supplement: Beverage 6
Dietary Supplement: Beverage 8
Dietary Supplement: Beverage 5
Dietary Supplement: Beverage 3
Dietary Supplement: Beverage 7

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Liquid foams can be formed by trapping pockets of gas in a beverage. The primary objective of this study is to test the individual contribution, and possible interaction, of the liquid volume and gas to liquid volume ratio (i.e. %overrun (%OR, defined as 100 x [gas volume/liquid volume]) of a beverage to its satiating properties.

Full description

It is not known how the liquid and gas volumes of a liquid foam contribute to its satiating properties and how and if these factors interact. The best way to assess these parameter combinations and their interactions is to use a special statistical approach named "Response Surface Methodology" (RSM). The current study therefore has a Central Composite Design with 9 foams differing in liquid volume and in ratio of gas to liquid volume (%overrun, which is defined as 100 x gas volume/liquid volume).

Each subject will be appointed to a single parameter combination and receives this parameter combination twice, separated by a one-week wash-out period.

On both test days subjects' self-assessment of feelings of satiety and physical discomfort will be recorded during 4 hours post-consumption of the treatment using Electronic Visual Analogue Scale.

Enrollment

96 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI between 21 and 32 kg/m²
  • Apparently healthy: measured by questionnaire: no reported current or previous metabolic diseases or chronic gastrointestinal disorders
  • Reported dietary habits: no medically prescribed diet, no slimming diet, used to eat 3 meals a day, no vegetarian.
  • Reported intense sporting activities below 10h/w
  • Reported alcohol consumption below 14 units/w (female volunteers) or below 21 units/w (male volunteers)

Exclusion criteria

  • Dislike, allergy or intolerance to test products or indicating to be unable to consume 514 ml of aerated test product
  • Any food allergy, or dislike or intolerance with the foods supplied during the study
  • Eating disorder (measured by SCOFF questionnaire, 2 or more"yes" responses) High or very high restrained eaters (measured by questionnaire; score of 15 or higher, Polivy et al. 1978)
  • Reported medical treatment that may affect eating habits/satiety
  • Reported lactating (or lactating < 6 weeks ago), pregnant (or pregnant < 6 months ago) or wish to become pregnant during the study

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

96 participants in 9 patient groups

Beverage 1
Other group
Description:
Liquid foam consisting of 37 ml liquid with 73% overrun (total volume 65 ml).
Treatment:
Dietary Supplement: Beverage 1
Beverage 2
Other group
Description:
Liquid foam consisting of 37 ml liquid with 427% overrun (total volume 197 ml).
Treatment:
Dietary Supplement: Beverage 2
Beverage 3
Other group
Description:
Liquid foam consisting of 98 ml liquid with 73% overrun (total volume 169 ml).
Treatment:
Dietary Supplement: Beverage 3
Beverage 4
Other group
Description:
Liquid foam consisting of 98 ml liquid with 427% overrun (total volume 514 ml).
Treatment:
Dietary Supplement: Beverage 4
Beverage 5
Other group
Description:
Liquid foam consisting of 25 ml liquid with 250% overrun (total volume 88 ml).
Treatment:
Dietary Supplement: Beverage 5
Beverage 6
Other group
Description:
Liquid foam consisting of 110 ml liquid with 250% overrun (total volume 385 ml).
Treatment:
Dietary Supplement: Beverage 6
Beverage 7
Other group
Description:
68 ml beverage consisting of 68 ml liquid with 0% overrun (total volume 68 ml).
Treatment:
Dietary Supplement: Beverage 7
Beverage 8
Other group
Description:
Liquid foam consisting of 68 ml liquid with 500% overrun (total volume 405 ml).
Treatment:
Dietary Supplement: Beverage 8
Beverage 9
Other group
Description:
Liquid foam consisting of 68 ml liquid with 250% overrun (total volume 236 ml).
Treatment:
Dietary Supplement: Beverage 9

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems